Central Proteina Financials

CPRO Stock  IDR 81.00  19.00  5.56%   
Financial data analysis helps to double-check if markets are presently mispricing Central Proteina Prima. We were able to interpolate twenty-seven available fundamental indicators for Central Proteina Prima, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Central Proteina Prima financials, including its price to sales, gross profit, and the relationship between the price to book and revenue . The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Central Proteina to be traded at 51.41 in 90 days.
With this module, you can analyze Central financials for your investing period. You should be able to track the changes in Central Proteina individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Central Proteina Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Central Proteina's financial statements are interrelated, with each one affecting the others. For example, an increase in Central Proteina's assets may result in an increase in income on the income statement.
Evaluating Central Proteina's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Central Proteina's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Central Proteina's relative financial performance

Chance Of Distress

Less than 10

 
100  
 
Zero
Low
Central Proteina Prima has less than 10 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Central Proteina stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Central Proteina's odds of distress score SHOULD NOT be confused with the real chance of Central Proteina Prima filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Central is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Central Proteina's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Central Proteina's official financial statements usually reflect Central Proteina's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Central Proteina Prima. For example, before you start analyzing numbers published by Central accountants, it's critical to develop an understanding of what Central Proteina's liquidity, profitability, and earnings quality are in the context of the Food Products space in which it operates.
Please note, the presentation of Central Proteina's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Central Proteina's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Central Proteina's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Central Proteina Prima. Please utilize our Beneish M Score to check the likelihood of Central Proteina's management manipulating its earnings.

Central Proteina Company Summary

Central Proteina competes with Protech Mitra, Galva Technologies, PT Boston, Envy Technologies, and Visi Media. PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people.
Foreign Associate
  USA
InstrumentIndonesia Stock View All
ExchangeJakarta Exchange
ISINID1000105000
Business AddressPuri Matari 2
SectorFood Products
IndustryConsumer Staples
BenchmarkNYSE Composite
Websitewww.cpp.co.id
Phone62 21 5019 1788
CurrencyIDR - Indonesian Rupiah
You should never invest in Central Proteina without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Central Stock, because this is throwing your money away. Analyzing the key information contained in Central Proteina's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Central Proteina Key Financial Ratios

Generally speaking, Central Proteina's financial ratios allow both analysts and investors to convert raw data from Central Proteina's financial statements into concise, actionable information that can be used to evaluate the performance of Central Proteina over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Central Proteina Prima reports annually and quarterly.

Central Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Central Proteina's current stock value. Our valuation model uses many indicators to compare Central Proteina value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Central Proteina competition to find correlations between indicators driving Central Proteina's intrinsic value. More Info.
Central Proteina Prima is number one stock in return on asset category among related companies. It is number one stock in cash flow from operations category among related companies making about  1,223,292,231,813  of Cash Flow From Operations per Return On Asset. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Central Proteina by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Central Proteina's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Central Proteina's earnings, one of the primary drivers of an investment's value.

Central Proteina Prima Systematic Risk

Central Proteina's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Central Proteina volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Central Proteina Prima correlated with the market. If Beta is less than 0 Central Proteina generally moves in the opposite direction as compared to the market. If Central Proteina Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Central Proteina Prima is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Central Proteina is generally in the same direction as the market. If Beta > 1 Central Proteina moves generally in the same direction as, but more than the movement of the benchmark.

About Central Proteina Financials

What exactly are Central Proteina Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Central Proteina's income statement, its balance sheet, and the statement of cash flows. Potential Central Proteina investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Central Proteina investors may use each financial statement separately, they are all related. The changes in Central Proteina's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Central Proteina's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Central Proteina Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Central Proteina is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Central has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Central Proteina's financials are consistent with your investment objective using the following steps:
  • Review Central Proteina's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Central Proteina's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Central Proteina's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Central Proteina's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Central Proteina March 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Central Proteina help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Central Proteina Prima. We use our internally-developed statistical techniques to arrive at the intrinsic value of Central Proteina Prima based on widely used predictive technical indicators. In general, we focus on analyzing Central Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Central Proteina's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Central Proteina Prima. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Central Stock analysis

When running Central Proteina's price analysis, check to measure Central Proteina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Central Proteina is operating at the current time. Most of Central Proteina's value examination focuses on studying past and present price action to predict the probability of Central Proteina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Central Proteina's price. Additionally, you may evaluate how the addition of Central Proteina to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Please note, there is a significant difference between Central Proteina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Central Proteina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Central Proteina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.